QuadMedicine, Inc. (KOSDAQ:464490)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,170
-1,130 (-7.90%)
At close: Apr 2, 2026

QuadMedicine Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23
151,219176,813--
Enterprise Value
131,186179,911--
Last Close Price
13170.0015590.00--
PS Ratio
14.1416.53--
PB Ratio
4.915.74--
P/TBV Ratio
5.015.85--
EV/Sales Ratio
12.2616.82--
Debt / Equity Ratio
0.240.240.640.72
Net Debt / Equity Ratio
-0.65-0.65-0.250.22
Net Debt / EBITDA Ratio
6.496.492.24-0.26
Net Debt / FCF Ratio
2.972.971.31-0.20
Asset Turnover
0.260.260.33-
Quick Ratio
2.752.751.801.14
Current Ratio
2.872.871.851.29
Return on Equity (ROE)
-32.69%-32.69%-48.32%-
Return on Assets (ROA)
-9.58%-9.58%-9.70%-
Return on Capital Employed (ROCE)
-15.80%-15.80%-17.30%-44.70%
Earnings Yield
-4.58%-3.92%--
FCF Yield
-4.46%-3.81%--
Buyback Yield / Dilution
-10.14%-10.14%-0.93%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.